Related references
Note: Only part of the references are listed.Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy
Ding Ai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Fat and beyond: The diverse biology of PPAR gamma
Peter Tontonoz et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Opposite Regulation of Cholesterol Levels by the Phosphatase and Hydrolase Domains of Soluble Epoxide Hydrolase
Ahmed E. EnayetAllah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model
Arzu Ulu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity
Bart M. De Taeye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Adiposity and cardiovascular disorders - Disturbance of the regulatory system consisting of humoral and neuronal signals
Hideki Katagiri et al.
CIRCULATION RESEARCH (2007)
Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice
Li-Fen Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo
Ding Ai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice
Ayala Luria et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Action of epoxyeicosatrienoic acids on cellular function
Arthur A. Spector et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system
Brandon T. Larsen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation
Ingrid Fleming
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss - An update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
P Poirier et al.
CIRCULATION (2006)
Diabetes and obesity: the twin epidemics
S Smyth et al.
NATURE MEDICINE (2006)
Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins
Y Xie et al.
DIABETES OBESITY & METABOLISM (2006)
The antiinflammatory effect of laminar flow:: The role of PPARγ, epoxyeicosatrienoic acids, and soluble epoxide hydrolase
Y Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension
JD Imig et al.
HYPERTENSION (2005)
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
KR Schmelzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension
O Jung et al.
HYPERTENSION (2005)
Vascular localization of soluble epoxide hydrolase in the human kidney
ZG Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Distribution of soluble epoxide hydrolase and of cytochrome P4502C8, 2C9, and 2J2 in human tissues
AE Enayetallah et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry
DB Friedman et al.
PROTEOMICS (2004)
CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products
TC DeLozier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Cloning, expression, and characterization of three new mouse cytochrome P450 enzymes and partial characterization of their fatty acid oxidation activities
H Wang et al.
MOLECULAR PHARMACOLOGY (2004)
11,12-Epoxyeicosatrienoic acid (11,12-EET):: Structural determinants for inhibition of TNF-α-induced VCAM-1 expression
JR Falck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity
JW Newman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells
HY Yan et al.
JOURNAL OF LIPID RESEARCH (2003)
TNF-α-induced endothelial cell adhesion molecule expression is cytochrome P-450 monooxygenase dependent
M Sasaki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process
L Madsen et al.
BIOCHEMICAL JOURNAL (2003)
Role of peroxisome proliferator-activated receptor-γ in maintenance of the characteristics of mature 3T3-L1 adipocytes
Y Tamori et al.
DIABETES (2002)
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension
JD Imig et al.
HYPERTENSION (2002)
Cytochrome P450CYP2J9, a new mouse arachidonic acid ω-1 hydroxylase predominantly expressed in brain
W Qu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation
CJ Sinal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
PPAR-γ agonists:: therapeutic role in diabetes, inflammation and cancer
GJ Murphy et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
ZG Yu et al.
CIRCULATION RESEARCH (2000)
Metabolism of monoepoxides of methyl linoleate: Bioactivation and detoxification
JF Greene et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators
V Pasceri et al.
CIRCULATION (2000)
Share Paper
